The use of fluoroquinolones in gonorrhoea: the increasing problem of resistance

Bibliography

• DONOVAN B, BODSWORTH NJ, ROHRSHEIM R, MCNULTY A, TAPSALL JW: Increasing gonorrhoea reports - not only in London.Lancet (2000) 355:1908.
   Google Scholar
• BERGLUND T, FREDLUND H, GIASCKE J: Epidemiology of the re-emergence of gonorrhea in Sweden. Sex. Bansm. Dis. (2001) 28:111–114.
   PubMedGoogle Scholar
• MARTIN IMC, ISON CA: Rise in gonorrhoea in London, UK.Lancet (2000) 355:623.
   PubMedGoogle Scholar
• GOULET V, SEDNAOUI P, LAPORTE A, BILLY C, DESENCLOS JC: The number of gonococcal infections identified by the RENACO network is increasing. Eurosurveillance (2000) 5:2–5.
   Google Scholar
• SERWAL S, WONG T, SEVIGNY C, NG L-K: Increasing frequency of ciprofloxacin-resistant N. gonorrhoeae infection in Canada. .1. Can. Med. Assoc. (2003) 168:872–873.
   Google Scholar
• CENTERS FOR DISEASE CONTROL AND PREVENTION: Sexually Transmitted Diseases Surveillance, 2002. Atlanta, GA: US Department of Health and Human Services, September 2003.
   Google Scholar
• LIND I: Antimicrobial resistance in Neisseria gonorrhoeae. Gin. Infect. Dis. (1997) 24\(Suppl. 1):593–597.
   Google Scholar
• ISON CA, DILLON J-AR, TAPSALL JW: The epidemiology of global antibiotic resistance among Neisseria gonorrhoeae and Hemophilus ducreyi. Lancet (1998) 351:8–11.
   PubMedGoogle Scholar
• ERBELDING E, QUINN TC: The impact of antimicrobial resistance on the treatment of sexually transmitted diseases. Infect. Dis. N Am. (1997) 4:889–903.
   Google Scholar
• MURATANI T, KOBAYASHI T, OSHI M et al.: The susceptibility of gonococcal isolates to penicillins, cephems, quinolones, tetracyclines, and spectinomycin in various area of Japan in 2002. Program and abstracts of the 15th Annual Meeting of theInternational Socien, of Sexually Transmitted Disease Research, Ottawa, Ontario, Canada. July 27–30 (2003) (Abstract 375).
   Google Scholar
• CENTERS FOR DISEASE CONTROL AND PREVENTION: 1998 Sexually transmitted diseases treatment guidelines. Morb. Mortal. Wkly Rep. (1998) 38:S8.
   Google Scholar
• PEELING RW, RONALD AR: Use of quinolones in sexually transmitted diseases. In: Quinolones Antimicrobial Agents (2'd edi). Hooper DC, Wolfson JS (Eds), American Society for Microbiology, Washington, DC, USA (1993):299–327.
   Google Scholar
• WANG JC: DNA topoisomerases. Ann. Rev Biochem. (1996) 65:635–692.
   PubMed Web of Science ®Google Scholar
• BELLAND RJ, MORRISON SG, ISON C, HUANG WM: Neisseria gonorrhoeae acquired mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates. MM. Microbiol (1994) 14:371–380.
   PubMed Web of Science ®Google Scholar
• ULLSPERGER C, COZZARELLI NR: Contrasting enzymatic activity of topoisomerase IV and DNA gyrase from Escherichia coli.,/ Biol. Chem. (1996) 271:31549–31555.
   PubMedGoogle Scholar
• SHULTZ TR, TAPSALL JW, WHITE PA: Correlation of in vitro susceptibilities to newer quinolones of naturally occurring quinolone-resistant Neisseria gonorrhoeaestrains with changes in GyrA and ParC. Antimicrob. Agents Chemother. (2001) 45:734-738.A recent study of the correlation between chromosomal mutations and in vitro activity of newer fluoroquinolones against resistant strains.
   Google Scholar
• CHEN LL, KOHLBRENNER WE, WEIGL D, BARANOWSKI J: Mechanism of quinolone inhibition of DNA gyrase. Appearance of unique norfloxacin binding sites in enzyme-DNA complexes.J. Biol. Chem. (1989) 264:2973–2978.
   Google Scholar
• ECHLOS RM, HEYD A, O'KEEFFE BJ, SCHACHT P: Single-dose ciprofloxacin for the treatment of uncomplicated gonorrhea: a worldwide summary. Sex. Transm. Dis. (1994) 21:345–352.
   PubMedGoogle Scholar
• PHANUCHARAS JP, GORBY GL: Differential intracellular efficacies of ciprofloxacin and cefixime against Neisseria gonorrhoeae in human fallopian tube organ culture. Antimicrob. Agents Chemother. (1997) 41:1547–1551.
   PubMedGoogle Scholar
• TAPSALL J: Current concepts in the management of gonorrhea. Expert Opin. Pharmacother. (2002) 3:147–157.
   PubMedGoogle Scholar
• ••A comprehensive recent review ofincidence, antibiotic resistance and treatment of gonorrhea.
   Google Scholar
• MORAN JS, LEVINE WC: Drugs of choice for the treatment of uncomplicated gonococcal infections. Clin. Infect. Dis. (1995) 20\(suppl 1);547–565.
   Google Scholar
• CENTERS FOR DISEASE CONTROL: 1989 Sexually transmitted diseases treatment guidelines. Morb. Mortal. Wkly Rep. (1989) 38:21–27.
   Google Scholar
• CENTERS FOR DISEASE CONTROL: 1993 Sexually transmitted diseases treatment guidelines. Morb. Mortal. Wkly Rep. (1993) 42:56–62.
   Google Scholar
• GRANSDEN WR, WARREN CA, PHILLIPS I, HODGES M, BARLOW D: Decreased susceptibility of Neisseria gonorrhoeae to ciprofloxacin. Lancet (1990) 335:51.
   PubMedGoogle Scholar
• JEPHCOTT AE, TURNER A: Ciprofloxacin resistance in gonococci. Lancet (1990) 335:165.
   PubMedGoogle Scholar
• BIRLEY H, MCDONALD P, CAREY P, FLETCHER J: High level ciprofloxacin resistance in Neisseria gonorrhoeae. Cenitourin. Med. (1994) 70:292–293.
   PubMedGoogle Scholar
• GRANSDEN WR, WARREN C, PHILLIPS I: 4-Fluoroquinolone-resistant Neisseria gonorrhoeae in the United Kingdom.' Med. Microbiol (1991) 34:23–27.
   Google Scholar
• CORKILL JE, PERCIVAL A, LIND M: Reduced uptake of ciprofloxacin in a resistant strain of N. gonorrhoeae and transformation of resistance to other strains. Antimicrob. Chemother. (1991) 28:601–604.
   PubMedGoogle Scholar
• TAPSALL JW, LOVETT R, MUNRO R: Failure of 500 mg ciprofloxacin therapy in male urethral gonorrhea. Med..]: Aust. (1992) 156: 143.
   PubMedGoogle Scholar
• CENTERS FOR DISEASE CONTROL AND PREVENTION: Fluoroquinolones resistance in Neisseria gonorrhoeae - Colorado and Washington, 1995.Morb. Mortal. Wkly Rep. (1995) 44:761–764.
   Google Scholar
• KAM KM, WONG PW, CHEUNG MM, HO NKY: Detection of fluoroquinolone-resistant Neisseria gonorrhoeae..1. Microbiol (1996) 34:1462–1464.
   Google Scholar
• RINGUETTE L, TRUDEAU T, TURCOTTE T et al.: Emergence of Neisseria gonorrhoeae strains with decreased susceptibility to ciprofloxacin - Quebec, 1994-1995. Can. Commun. Dis. Rep. (1996) 22:121–125.
   PubMedGoogle Scholar
• TURNER A, GOUGH KR,JEPHCOTT AE, MCLEAN AN: Importation into the UK of a strain of Neisseria gonorrhoeae resistant to penicillin, ciprofloxacin and tetracycline.Cenitourin. Med. (1995) 71:331–332.
   PubMedGoogle Scholar
• TAPSALL JW, PHILLIPS EA,SHULTZ TR, THACKER C: Quinolone-resistant Neisseria gonorrhoeae in Sidney, Australia, 1991 to 1995. Sex. Transm. Dis. (1996) 23:425–428.
   PubMed Web of Science ®Google Scholar
• KNAPP JS, HALE JA, NEAL SW, WINTERSHEID K, RICE RJ, WITTINGTON WI: Proposed criteria for interpretation of susceptibilities to strains of Neisseria gonorrhoeae to ciprofloxacin, ofloxacin, enoxacin, lomefloxacin, and norfloxacin. Antimicrob. Agents Chemother: (1995) 39:2442–2445.
   PubMedGoogle Scholar
• KNAPP JS, FOX KK, TREES DL, WHITTINGTON WL: Fluoroquinolones resistance in Neisseria gonorrhoeae. Emeig. Infect. Dis. (1997) 3:33–39.
   PubMedGoogle Scholar
• ••An important review of the mechanismsand distribution of gonococcal resistance to fluoroquinolones.
   Google Scholar
• IVENS D, MARTIN I, ISON C: Neisseria gonorrhoeae in a London sexually transmitted infection clinic not fully sensitive to quinolones: are isolates imported and how effective is ciprofloxacin as a firs-line therapy. Int..]: STD AIDS (2000) 11:774–776.
   PubMedGoogle Scholar
• ISON CA, WOODFORD PJ, MADDERS H, CLAYTON E: Drift in susceptibility of Neisseria gonorrhoeae to ciprofloxacin and emergence of therapeutic failure. Antimicrob. Agents Chemother. (1998) 42:2919–2922.
   PubMed Web of Science ®Google Scholar
• HANDSFIELD HH, WITTINGTON WL: Antibiotic-resistant Neisseria gonorrhoeae: the calm before another storm. Ann. Intern. Med. (1996) 125:507–509.
   PubMedGoogle Scholar
• Annual Report Of The Australian Gonococcal Surveillance Programme 2000: Commun. Dis. Intel] (2001) 25:59–63.
   Google Scholar
• ••An example of National programmes forthe surveillance of gonococcal susceptibility.
   Google Scholar
• FORAYTH A, MOYES A, YOUNG H: Increased ciprofloxacin resistance in gonococci isolated in Scotland. Lancet (2000) 356:1984–1985.
   PubMedGoogle Scholar
• COMMUNICABLE DISEASES NETWORK AUSTRALIA: Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2001. Commun. Dis. Intel] (2002) 26:541–545.
   PubMedGoogle Scholar
• O'DONNELL JA, GELONE SP: Fluoroquinolones. Infect. Dis. Clin. N Am. (2000) 14:489–513.
   Google Scholar
• HOOPER DC: Emerging mechanisms of fluoroquinolone resistance. Emeig. Infect. Dis. (2001) 7; 337–341.
   PubMed Web of Science ®Google Scholar
• DEGUCHI T, YASUDA M, NAKANO M et al.: Uncommon occurrence of mutations in the gyrB gene associated with quinoloneresistance in clinical isolates of Neisseria gonorrhoeae. Antimicrob. Agents Chemother:(1996) 40:2437–2438.
   PubMedGoogle Scholar
• SU X, LIND I: Molecular basis of high-level ciprofloxacin resistance in Neisseria gonorrhoeae strains isolated in Denmark from 1995 to 1998. Antimicrob. Agents Chemother: (2001) 45:117–123.
   Google Scholar
• ••A prospective genetic analysis ofquinolone-resistant strains that identifies the important mutations and establishes these as the underlying mechanism of QRNG.
   Google Scholar
• TANAKA M, MATSUMOTO T, SAKUMOTO M et al.: Reduced clinical efficacy of pazufloxacin against gonorrhea due to high prevalence of quinolone-resistant isolates with the GyrA mutation. Antimicrob. Agents Chemother. (1998) 42:579–582.
   PubMedGoogle Scholar
• NG L-K, SAWATZKY P, MARTIN IE, BOOTH S: Characterization of ciprofloxacin resistance in Neisseria gonorrhoeae isolates in Canada.Sex. Transm. Dis. (2002) 29:780–789.
   PubMedGoogle Scholar
• KAM KM, LO KK, LAI CF, LEE YS, CHAN CB: Ofloxacin susceptibilities of 5,667 Neisseria gonorrhoeae strains isolated in Hong Kong. Antimicrob. Agents Chemother: (1993) 37:2007–2008.
   Google Scholar
• KAM KM, KAM SS, CHEUNG DT, TUNG VW, AU WE CHEUNG MM: Molecular characterization of quinolone-resistant Neisseria gonorrhoeae in Hong Kong. Antimicrob. Agents Chemother. (2003) 47:436–439.
   PubMedGoogle Scholar
• TREES DL, SANDUL AL, PETO-MESOLA V et al.: Alterations within the quinolone resistance-determining regions of GyrA and ParC of Neisseria gonorrhoeae isolated in the Far East and the United States. Int.Antimicrob. Agents (1999) 12:325–332.
   PubMed Web of Science ®Google Scholar
• ••An extensive study of the chromosomal mutations associated with quinolone resistance of gonococci.
   Google Scholar
• TANAKA M, NAKAYAMA H,HARAOKA M, SAIKA T, KOBAYASHI I, NAITO S: Antimicrobial resistance of Neisseria gonorrhoeae and high prevalence of ciprofloxacin-resistant isolates in Japan, 1993-1998.j Clin. Microbiol (2000) 38:521–525.
   PubMedGoogle Scholar
• OTERO L, ALCALA B, VARELA JA, MIGUEL MD, VAZQUEZ JA, VAZQUEZ F: The first isolate of a Neisseria gonorrhoeae strain associated withan ofloxacin treatment failure in Spain: case report. Sex. Transm. Dis. (2001) 28:576–578.
   PubMedGoogle Scholar
• LINDBACK E, RAHMAN M, JALAL S, WRETLIND B: Mutations in gyrA, gyrB, parC, and parE in quinolone-resistant strains of Neisseria gonorrhoeae. AMPIS (2002) 110:651–657.
   Google Scholar
• TANAKA M, NAKAYAMA H,HARAOKA M, SAIKA T, KOBAYASHI I, NAITO S: Susceptibility of Neisseria gonorrhoeae isolates containing amino acid substitutions in GyrA, with or without substitutions in ParC, to newer fluoroquinolones and other antibiotics. Antimicrob. Agents Chemother: (2000) 44:192–195.
   PubMed Web of Science ®Google Scholar
• TREES DL, SANDUL AL, WHITTINGTON WL, KNAPP JS: Identification of novel mutations patterns in the ParC gene of ciprofloxacin-resistant isolates of Neisseria gonorrhoeae. Antimicrob. Agents Chemother: (1998) 42:2103–2105.
   PubMedGoogle Scholar
• DEGUCHI T, YASUDA M, NAKANO M et al.: Quinolone-resistant Neisseria gonorrhoeae: correlation of alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV with antimicrobial susceptibility profiles. Antimicrob. Agents Chemother: (1996) 40:1020–1023.
   PubMed Web of Science ®Google Scholar
• TANAKA M, SAKUMA S, TAKAHASHI K et al.: Analysis of quinolone resistance mechanisms in Neisseria gonorrhoeae isolates in vitro. Sex. Transm. Infect. (1998) 74:59–62.
   PubMedGoogle Scholar
• MAVROIDI A, TZOUVELEKIS LS, TASSIOS PT, FLEMETAKIS A, DANILIDOU M, TZELEPI E: Characterization of Neisseria gonorrhoeae strains with decreased susceptibility to fluoroquinolones isolated in Greece from 1996 to 1999.j Clin. Microbiol (2000) 38:3489–3491.
   PubMedGoogle Scholar
• DE NEELING AJ,VAN SENTEN-VERHEUEL M, SRAARGAREN J, WILLEMS RJL: Antimicrobial resistance of Neisseria gonorrhoeae and emerging ciprofloxacin resistance in the Netherlands, 1991–1998. Antimicrob. Agents Chemother: (2000) 44:3184–3185
   Google Scholar
• GILES J, YEUNGER J, ZENILMAN J, DAN M, BASH M: Characterization of porin type and QRDR mutation in ciprofloxacin resistant strains of Neisseriagonorrhoeae from Israel. Program and Abstracts of the 15' Annual Meeting of the International Socieo, of Sexually Transmitted Disease Research, Ottawa, Ontario, Canada. July 27–30 (2003) Abstract 459.
   Google Scholar
• LKHAMSUREN E, SHULTZ TR, LIMNIOS EA, TAPSAL JW: The antibiotic susceptibility of Neisseria gonorrhoeae isolated in Ulaanbaatar, Mongolia. Sex. Transm Infect. (2001) 77:218–220.
   PubMed Web of Science ®Google Scholar
• TREES DL, SANDUL AL, NEAL SW et al.: Molecular epidemiology of Neisseria gonorrhoeae exhibiting decreased susceptibility and resistance to ciprofloxacin in Hawaii, 1991-1999. Sex. Transm. Dis. (2001) 28:309–314.
   PubMed Web of Science ®Google Scholar
• CHAUDHRY U,RAY K, BALA M, SALUJA D: Mutation patterns in gyrA and parC genes of ciprofloxacin resistant isolates of Neisseria gonorrhoeae from India. Sex. Transm. Infect. (2002) 78:440–444.
   PubMedGoogle Scholar
• KNAPP JS, MESOLA V, NEAL SW et al: Molecular epidemiology, in 1994, of Neisseria gonorrhoeae in Manila and Cebu City, Republic of the Philippines.Sex. Transm. Dis. (1997) 24:2–7.
   PubMedGoogle Scholar
• KNAPP JS, WONGBA C, LIMPAKARNJANARAT K et al.: Antimicrobial susceptibility of strains of Neisseria gonorrhoeae in Bangkok, Thailand: 1994-1995. Sex. Transm. Dis. (1997) 24:142–148.
   PubMedGoogle Scholar
• TREES DL, SIRIVONGRANGSON P, SCHULTZ AJ et al: Multiclonal increase in ciprofloxacin-resistant Neisseria gonorrhoeae, Thailand, 1998-1999. Sex. Transm. Dis. (2002) 29:668–673.
   PubMedGoogle Scholar
• HARNETT N, BROWN S, RILEY G et al.: Analysis of Neisseria gonorrhoeae in Ontario, Canada, with decreased susceptibility to quinolone by pulsed-field gel electrophoresis, auxotyping, serotyping and plasmid content. Med. Microbiol (1997) 46:383–390.
   PubMedGoogle Scholar
• GORDON SM, CARLYN CJ, DOYLE LJ et al.: The emergence of Neisseria gonorrhoeae with decreased susceptibility to ciprofloxacin in Cleveland, Ohio: epidemiology and risk factors. Ann. Intern. Med. (1996) 125:465–470.
   PubMedGoogle Scholar
• YAGUPSKY P, SCHAHAR A, PELED N et al.: Increasing incidence of gonorrhea in Israel associated with countrywide dissemination of a ciprofloxacin resistant strain. Eur. I Clin. MicrobioL Infect. Dis. (2002) 2:268–272.
   Google Scholar
• TANAKA M, FUKUDA II, HIRAI K et al:Reduced uptake and accumulation of norfloxacin in resistant strains of Neisseria gonorrhoeae isolated in Japan.Cenitourin. Med. (1994) 70:253–255.
   PubMedGoogle Scholar
• •One of the first reports on another mechanism of gonococcal resistance consisting of alterations in the permeation of the drug to reach its site of action.
   Google Scholar
• HOOPER DC, WOLFSON JS, NG EY et al.: Mechanisms of action and resistance to ciprofloxacin. Am. .1. Med. (1987) 82:12–20.
   Google Scholar
• DEGUCHI T, SAITO I, TANAKA M et al.: Fluoroquinolone treatment failure in gonorrhea: emergence of a Neisseria gonorrhoeae strain with enhanced resistance to fluoroquinolones. Sex. Transm. Dis. (1997) 24:247–250
   PubMed Web of Science ®Google Scholar
• •One of first studies suggesting that quinolone resistance increases with multiple quinolone therapies and that cross-resistance to cephalosporins can develop.
   Google Scholar
• TANAKA M, SAKUMA S,TAKAHASHI K et al.: Analysis of quinolone resistance mechanisms in Neisseria gonorrhoeae isolates in vitro. Sex. Transm. Infect. (1998) 74:59–62.
   Google Scholar
• WEISFUSE IR: Gonorrhea control and antimicrobial resistance.Lancet (1998) 351:928.
   PubMedGoogle Scholar
• KNAPP JS, NEAL SW, PAREKH MC, RICE J: In vitro activity of a new fluoroquinolones, CP-99,219 against strains of Neisseria gonorrhoeae. Antimicrob. Agents Chemother: (1995) 39:987–989.
   Google Scholar
• JONES RN, BARRETT MS,DEGUCHI T: Antimicrobial activity of trovafloxacin tested against ciprofloxacin-susceptible and -resistant Neisseria gonorrhoeae. Interpretive criteria and comparisons with Etast results.Diagn. Microbiol Infect. Dis. (1997) 28:193–200.
   PubMedGoogle Scholar
• JONES RN, DESHPANDE LM, ERWIN ME, BARRETT MS,BEACH ML: Anti-gonococcal activity of gemifloxacin against fluoroquinolone-resistant strains and a comparison of agar dilution and Etest methods. j. Antimicrob. Chemother: (2000) 45\(Suppl. 1):67–70.
   Google Scholar
• BERRON S, VASQUEZ JA,GIMENEZ MJ, DE LA FUENTE L, AGUILAR L: In vitro susceptibility of 400 Spanish isolates of Neisseria gonorrhoeae to gemifloxacin and 11 otherantimicrobial agents. Antimicrob. Agents Chemother. (2000) 44:2543–2544.
   PubMedGoogle Scholar
• TANAKA M, TUNOE H, MOCHIDA 0 et al: Antimicrobial activity of gemifloxacin (SB-265805), a newer fluoroquinolones, against clinical isolates of Neisseria gonorrhoeae, including fluoroquinolones-resistant isolates. Diagn. MicrobiolInfect. Dis. (2000) 38:109–113.
   PubMedGoogle Scholar
• BIEDENBACH DJ, BEACH ML, JONES RN: Antimicrobial activity of gatifloxacin against Neisseria gonorrhoeae using three methods and a collection of fluoroquinolones-resistant strains. Diagn. Microbiol Infect. Dis. (1998) 32:307–311.
   PubMedGoogle Scholar
• CARLYN CJ, DOYLE LJ, KNAPP CC, LUDWIG MD, WASHINGTON JA: Activities do three investigational fluoroquinolones (BAY y 3118, DU-6859a, and clinafloxacin) against Neisseria gonorrhoeae isolates with diminished susceptibility to ciprofloxacin and ofloxacin. Antimicrob. Agents Chemother. (1995) 39:1606–1608.
   PubMedGoogle Scholar
• KLAUSNER JD, APLASCA M-R, MESOLA VP, BOLAN G, WHITTINGTON WL, HOLMES KK: Correlates pf gonococcal infection and of antimicrobial-resistant Neisseria gonorrhoeae among female sex workers, Republic of the Philippines, 1996-1997.Infect. Dis. (1999) 179:729–733.
   Google Scholar
• KNAPP JS, OHYE R, NEAL SW, PAREKH MC, HIGA H, RICE RJ: Emerging in vitro resistance to quinolones in penicillinase-producing Neisseria gonorrhoeae strains in Hawaii. Antimicrob. Agents Chemother. (1994)38:2200–2203.
   PubMed Web of Science ®Google Scholar
• TAPSALL JW, SHULTZ TR,PHILLIPS AE: Characteristics of Neisseria gonorrhoeae isolated in Australia showing decreased sensitivity to fluoroquinolone antibiotics. Pathology (Phil& (1992) 24:27–31.
   Google Scholar
• BERGLUND T, UNEMO M, OLCEN P, GIESECKE J, FREDLUND H: One year of Neisseria gonorrhoeae isolates in Sweden: the prevalence study of antibiotic susceptibility shows relation to the geographic area of exposure.Int.j STD AIDS (2002) 13:109–114.
   PubMed Web of Science ®Google Scholar
• TAYAL SC, SANKAR KN,PATTMAN RS, WATSON PG, GALLOWAY A: Neisseria gonorrhoeae in Newcastle upon Tyre 1995-1997: increasein ciprofloxacin resistance.Int.j STD AIDS (1999) 10:290–293.
   PubMedGoogle Scholar
• PATRICK D, SHAW C, REKART ML: Neisseria gonorrhoeae with decreased susceptibility to ciprofloxacin in British Columbia: an imported phenomenon. Can. Commun. Dis. Rep. (1995) 21:137–139.
   PubMedGoogle Scholar
• MACAULAY ME: Acrosoxacin resistance inNeisseria gonorrhoeae. Lancet (1982) 1:171–172.
   PubMedGoogle Scholar
• TANAKA M, KUMAZAWA J, MATSUMOTO T, KOBAYASHI I: High prevalence of Neisseria gonorrhoeae strains with reduced susceptibility to fluoroquinolones in Japan. Cenitourin. Med. (1994) 70:90–93.
   PubMedGoogle Scholar
• GRANSDEN WR, WARREN CA, PHILLIPS I, HODGES M, BARLOW D: Decreased susceptibility of Neisseria gonorrhoeae to ciprofloxacin.Lancet (1990) 335:51.
   PubMedGoogle Scholar
• WAGENVOORT JHT,VAN DER WILLINGEN AH, VAN VLIET HJ, MICHEL ME VAN KLIGEREN B: Resistance of Neisseria gonorrhoeae to enoxacin.Antimicrob. Chemother: (1986) 18:429.
   Google Scholar
• CLENDENNEN TE, HAMES CS, KEES ES et al.: In vitro antibiotic susceptibilities of Neisseria gonorrhoeae isolates in the Philippines. Antimicrob. Agents Chemother. (1992) 36:277–282.
   PubMed Web of Science ®Google Scholar
• YEUNG KH, DILLON JR: Norfloxacin resistant Neisseria gonorrhoeae inNorth America. Lancet (1990) 336:759.
   PubMedGoogle Scholar
• DIVEKAR AA, GOGATE AS,SHIVKAR LK: Association between auxotypes, serogroups, and antibiotic susceptibilities of Neisseria gonorrhoeae isolated from women in Mumbai (bombay), India. Sex. Transm. Dis. (1999) 26(6):358–363.
   PubMedGoogle Scholar
• RAY K, BALA M, KUMAR J, MISRA RS: Trend of antimicrobial resistance in N. gonorrhoeae at New Delhi, India. Int.j STD AIDS (2000) 11:115–118.
   PubMedGoogle Scholar
• BALA M, RAY K, KUMARI S: Alarming increase in ciprofloxacin- and penicillin-resistant Neisseria gonorrhoeae isolates in New Delhi, India. Sex. Transm. Dis. (2003) 30:523–525.
   PubMedGoogle Scholar
• BHUIYAN BU, RAHMEN M, MIAH RA et al.: Antimicrobial susceptibility and plasmid content of N. gonorrhoeae isolated from commercial sex workers in Dhaka,Bangladesh: emergence of high level resistance to ciprofloxacin. ./. Clin. Microbiol (1999) 37:1130–1136.
   Google Scholar
• RAHMAN M, SULTAN Z, MONIRA S et al.: Antimicrobial susceptibility of Neisseria gonorrhoeae isolated in Bangladesh (1997-1999): rapid shift to fluoroquinolone resistance. J. Clin. Microbiol (2002) 40:2037–2040.
   PubMedGoogle Scholar
• RAHMAN M, ZAFAR S, MONIRA S et al.: Antimicrobial susceptibility of Neisseria gonorrhoeae isolated from Bangladesh (1997–2002) rapid shift to fluoroquinolone and multidrug resistance. Program and Abstracts of the 15th Annual Meeting of the International Society of Sexually Transmitted Disease Research, Ottawa, Ontario, Canada. July 27–30 (2003) Abstract 620.
   Google Scholar
• NATIONAL CENTRE FOR DISEASE CONTROL/COMMUNICABLE DISESES NETWORK AUSTRALIA NEW ZELAND: Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 1998. Commun. Dis. Intel] (2000) 24:1–4.
   PubMedGoogle Scholar
• DAN M, POCH F, SHEINBERG B: High prevalence of high-level ciprofloxacin resistance in N. gonorrhoeae in Tel Aviv, Israel: correlation with response to therapy. Antimicrob. Agents Chemother. (2002) 46:1671–1673.
   PubMedGoogle Scholar
• DORLENCOURT F, BOIREUX C, SEDNAOUI P, DANIELENKO NV, LEGROS D: In vitro susceptibility of 120 strains of Neisseria gonorrhoeae isolated in Kyrghyzstan. Sex. Transm. Dis. (2002) 29:376–379.
   PubMed Web of Science ®Google Scholar
• FENTON KA, ISON C, JOHNSON AP et al.: Ciprofloxacin resistance in Neisseria gonorrhoeae in England and Wales. Lancet (2003) 361:1867–1869.
   PubMedGoogle Scholar
• NISSINEN A, JARVINEN H, LIIMATAINEN 0, JAHKOLA M, HUOVINEN P: Antimicrobial resistance in Neisseria gonorrhoeae in Finland, 1976 to 1995. Sex. Transm. Dis. (1997) 24:576–581.
   PubMedGoogle Scholar
• DRAGSTED D, POULSEN P, NORGAARD C, LIND I: Antimicrobial susceptibility of Neisseria gonorrhoeae strains isolated in Nuuk, Greenland during 1998-1999. Int. J. STD AIDS (2002) 13:826–828.
   PubMed Web of Science ®Google Scholar
• SEKHINE SV, STRATCHOUNSKI LS: Resistance to antibiotics in Neisseria gonorrhoeae in Russia: there is something to
   Google Scholar
• ••worry about. J. Antimicrob. Chemother: (1999) 44(Suppl. A):81.
   Google Scholar
• ZENILMAN JM: Update on quinolone resistance in Neisseria gonorrhoeae. Curt-. Infect. Dis. Rep. (2002) 4:144–147.
   PubMedGoogle Scholar
• WANG SA, HARVEY AB, CONNER AM et al.: Gonococcal susceptibility and epidemiological trends: data from the Gonococcal Isolate Surveillance Project, United States, 2002. Program and Abstracts of the 15" Annual Meeting of the International Society of Sexually Transmitted Disease Research, Ottawa, Ontario, Canada. July 27–30 (2003) Abstract 284.
   Google Scholar
• LLANES R, SOSA J, GUZMAN D et al.: Antimicrobial susceptibility of Neisseria gonorrhoeae in Cuba (1995-1999): implications for treatment of gonorrhea. Sex. Transm. Dis. (2003) 30:10–14.
   PubMedGoogle Scholar
• LLANES R, ZAMORA A, NAPOLES M et al.: Antimicrobial resistance ofNeisseria gonorrhoeae in the municipality of Moron, Cuba: emergence of isolates with intermediate resistance to fluoroquinolones. Antimicrob. Chemother:(2003) 51:191–192
   Google Scholar
• DILLON J-AR, LI H, SEALU J, RUBEN M, PRABHAKAR P: Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from three Caribbean countries: Trinidad, Guyana, and St. Vincent. Sex. Transm. Dis. (2001) 28:508–514.
   PubMedGoogle Scholar
• FAMIGLIETTI A, GARCIA SD, DE MIER CA et al.: Evaluation of Neisseria gonorrhoeae drug susceptibility in Buenos Aires, Argentina, 1985–1999. Sex. Transm. Infect. (2001) 77:142.
   Google Scholar
• MOODLEY P, STURM AW: Ciprofloxacin resistance in Neisseria gonorrhoeae. Lancet (2001) 357:1295–1296.
   PubMedGoogle Scholar
• TAPSALL JW, LIMNIOS EA, SHULTZ TR: Continuing evolution of the pattern of quinolone resistance in N. gonorrhoeae isolated in Sydney, Australia. Sex. Transm. Dis. (1998) 25:415–417.
   PubMed Web of Science ®Google Scholar
• ••Description of the transition of quinoloneresistance from an imported phenomenon into a endemic problem, with emphasis on the role of international sex workers.
   Google Scholar
• TOMPKINS JR, ZENILMAN JM: Quinolone resistance in Neisseria gonorrhoeae. Curt: Infect. Dis. Rep. (2001) 3:156–161.
   PubMedGoogle Scholar
• KAM KM, LAI CE EGGLESTONE S, CHAN CB: Pattern of antibioticsusceptibility of gonococci isolated in Hong Kong, 1987-1990. Sex. Transm. Dis. (1992) 19:284–287.
   PubMedGoogle Scholar
• KAM K-M, LO K-K, NG K-Y-H, CHEUNG M-M: rapid decline in penicillinase-producing Neisseria gonorrhoeae in Hong Kong associated with emerging 4-fluoroquinolone resistance. Genitourin. Med. (1995) 71:141–144.
   PubMedGoogle Scholar
• ALPASCA DE LOS REYES MR, PATO-MESOLA V, KLAUSNER JD et al.: A randomised trial of ciprofloxacin versus cefixime for treatment of gonorrhea after rapid emergence of gonococcal ciprofloxacin resistance in the Philippines. Clin. Infect. Dis. (2001) 32:1313–1318.
   PubMedGoogle Scholar
• ••A well-done clinical trial in high prevalenceQRNG region correlating in vitro resistance with therapeutic failure.
   Google Scholar
• YE S, SU X, WANG Q, YIN Y, DAI X, SUN H: Surveillance of antibiotic resistance of Neisseria gonorrhoeae isolates in China, 1993-1998. Sex. Transm. Dis. (2002) 29:242–245.
   PubMed Web of Science ®Google Scholar
• GU W, YANG Y, WU L, GAO Z, WANG H, LIAO M: Surveillance of antibiotic susceptibility of Neisseria gonorrhoeae in Shanghai:1988-2002. Program and Abstracts of the 15' Annual Meeting of the International Society of Sexually Transmitted Disease Research, Ottawa, Ontario, Canada. July 27–30 (2003) Abstract 99.
   Google Scholar
• CHEN C, TUMPEY A, MIKA J et al.: High prevalence of ciprofloxacin resistance in Neisseria gonorrhoeae strains isolated in Guangzhou, China. Program and Abstracts of the 15" Annual Meeting of the International Society of Sexually Transmitted Disease Research, Ottawa, Ontario, Canada.July 27–30 (2003) (Abstract 188).
   Google Scholar
• CLENDENNEN TE, ECHEVERRIA P, SAENGEUR S, KEES ES, BOSLEGO JW, WIGNALL FS: Antibiotic susceptibility survey of Neisseria gonorrhoeae in Thailand. Antimicrobial. Agents Chemother. (1992) 36:1682–1687.
   PubMed Web of Science ®Google Scholar
• LESMANA M, LEBRON CI, TASLIM D et al.: In vitro antibiotic susceptibility of Neisseria gonorrhoeae in Jakarta, Indonesia. Antimicrob. Agents Chemother. (2001) 45:359–362.
   PubMedGoogle Scholar
• IEVEN M, VAN LOOVEREN M, SUDIGDOADI S et al.: Antimicrobial susceptibilities of Neisseria gonorrhoeae strains isolated in Java, Indonesia. Sex. Transm. Dis. (2003) 30:25–29.
   PubMed Web of Science ®Google Scholar
• SU X, HUTAPEA N, TAPSALL JVV, LIND I: Plasmid mediated resistance of Neisseria gonorrhoeae strains isolated from female sex workers in North Sumatra, Indonesia, 1996. Sex. Transm. Dis. (2003) 30:178–182.
   PubMed Web of Science ®Google Scholar
• JOESOEF MR, KNAPP JS, IDAJANI A et al.: Antimicrobial susceptibilities of Neisseria gonorrhoeae strains in Surabaya, Indonesia. Antimicrob. Agents Chemother: (1994) 38:2530–2533.
   PubMedGoogle Scholar
• DAN M, POCH F, SPITZ D,SHEINBERG B: High level ciprofloxacin resistance in N. gonorrhoeae: first report from Israel. Emerg. Infect. Dis. (2001) 7:158–159.
   PubMedGoogle Scholar
• AL-HATTAWI K, ISON CA.Characteristics of gonococci isolated from men with urethritis in Dubai. Epidemiol. Infect. (1996)116:15–20.
   Google Scholar
• ALCALA B, ARREAZA L, SALCEDO C et al.: Molecular characterization of ciprofloxacin resistance of gonococcal strains in Spain. Sex Transm. Dis. (2003) 30:395–398.
   PubMed Web of Science ®Google Scholar
• WAGNERJ, TEBBE B, HORNLE R et al.: Antibiotic susceptibility of Neisseria gonorrhoeae isolates in Berlin. Hautarzt (2000) 51:666–669.
   PubMedGoogle Scholar
• ISON CA, BRANLEY NS, KIRKLAND K, EASMON CSF: Surveillance of antibiotic resistance in clinical isolates of Neisseria gonorrhoeae. Br. Med. J. (1991) 303:1307–1308.
   PubMedGoogle Scholar
• ISON CA, MARTIN IMC: Gonorrhoea in London: usefulness of first line therapies. Sex. Transm. Infect. (2002) 78:106–109.
   PubMedGoogle Scholar
• CORKILL JE, KOMOLAFE AJ, NEAL TJ, MORTIMORE A, ALLAWATTAGAMA AB, HART CA: Molecular epidemiology of endemic ciprofloxacin-resistant Neisseria gonorrhoeae in Liverpool.Int.j STD AIDS (2003) 14:379–385.
   PubMedGoogle Scholar
• LEWIS DA, BROOK MG, SHAFI MS: High level ciprofloxacin resistant gonorrhea imported from Russia. Genitourin. Med. (1997) 73:325–326.
   PubMedGoogle Scholar
• EHRET JM, JUDSON FN: Quinolone-resistant Neisseria gonorrhoeae: the beginning of the end? Report of quinolone-resistant isolates and surveillance in the Southwestern United States, 1989 to 1997. Sex. Transm. Dis. (1998) 25:522–526.
   PubMedGoogle Scholar
• GORWITZ RJ, NAKASHIMA AK, MORAN JS, KNAPP JS, and the
   Google Scholar
• ••GONOCOCCAL ISOLATE SURVEILLANCE PROJECT STUDY GROUP: Sentinel surveillance for antimicrobial resistance in Neisseria gonorrhoeae - United States, 1988–1991. Morbid. Mortal Weekly Rep. (1993) 42(Suppl. SS-3):29–39.
   Google Scholar
• FOX KK, KNAPP JS, HOLMES KK et al: Antimicrobial resistance in Neisseria gonorrhoeae in the United States,1988-1994: the emergence of decreasedsusceptibility to the fluoroquinolones.Infect. Dis. (1997) 175:1396–1403.
   Google Scholar
• KNAPP JS, WASHINGTON JA, DOYLE IJ et al.: Persistence of Neisseria gonorrhoeae strains with reduced susceptibility to ciprofloxacin and ofloxacin in Cleveland, Ohio from 1992 through 1993. Antimicrob. Agents Chemother. (1994) 38:2194–2196.
   PubMedGoogle Scholar
• KILMARX PH, KNAPP JS, XIA M et al: Intercity spread of gonococci with decreased susceptibility to fluoroquinolones: a unique focus in the United States.' Infect. Dis. (1998) 177:677–682.
   Google Scholar
• KATZ AR, LEE MVC, OHYE RG, WHITICAR PM, EFFLER: Ciprofloxacin resistance in Neisseria gonorrhoeae: trends in Hawaii, 1997-2002. Lancet (2003) 362:495.
   PubMedGoogle Scholar
• CENTERS FOR DISEASE CONTROL AND PREVENTION: Fluotoquinolone-resistant Neisseria gonorrhoeae -San Diego, California, 1997. MMWR Morb. Mort. Wkly Rep. (1998) 47:405–408.
   PubMedGoogle Scholar
• CENTERS FOR DISEASE CONTROL AND PREVENTION: Increase in fluoroquinolone- resistant Neisseria gonorrhoeae Hawaii and California, 2001. MMWR Morb. Mort. Wkly Rep. (2002) 51:1041–1044.
   PubMedGoogle Scholar
• CENTERS FOR DISEASE CONTROL AND PREVENTION: Sexually transmitted disease surveillance 2001 supplement: Gonococcal Isolates Surveillance Project (GISP) annual report 2001. Atlanta, Georgia: US department of Health and Human Services, October, 2002.
   Google Scholar
• ••An example of National programmes forthe surveillance of gonococcalsusceptibility: city-by-city summery data, data on drug therapy and trends.
   Google Scholar
• CENTERS FOR DISEASE CONTROL AND PREVENTION: Sexually transmitted diseases treatment guidelines 2002. MMWR Morb. Mort. Wkly Rep. (2002) 51:1–78.
   Google Scholar
• ••Recommendations for the treatment of gonococcal and other STIs.
   Google Scholar
• ZENILMAN J: Gonococcal susceptibility to antimicrobials in Baltimore, 1988-1994. Sex. Transm. Dis. (1996) 23:213–218.
   PubMedGoogle Scholar
• LLANES R, SOSA J, GUZMAN D, GUTIERREZ Y, LLOP A, RICARDO 0: Neisseria gonorrhoeae resistant to ciprofloxacin: first report in Cuba.Sex. Transm. Dis. (2001) 28:82–83.
   PubMedGoogle Scholar
• SWANSTON WH, Al C, MAHABIR BS, PRABHAKAR P, BASRAJ S, GEORGE J: Antibiotic susceptibility of Neisseria gonorrhoeae in Trinidad and Tobago.West Indian Med. .1. (1997) 46:107–110.
   PubMedGoogle Scholar
• DILLON J-AR, RUBABAZA J-PA, SCHWARTZ BENZAKEN A et al:Reduced susceptibility to azithromycin and high percentages of penicillin and tetracycline resistance in Neisseria gonorrhoeae isolates from Manaus, Brazil, 1998. Sex. Trans. Dis. (2001) 28:521–526.
   PubMedGoogle Scholar
• FIORITO S, GALARZA P, PAGANO I et al.: Emergence of high level ciprofloxacin resistant Neisseria gonorrhoeae strain in Buenos Aires, Argentina. Sex. Transm. Infect. (2001) 77:77.
   PubMedGoogle Scholar
• VAN DYKE E, KARITA E, ABDELLATI S et al.: Antimicrobial susceptibility of Neisseria gonorrhoeae in Kigali Rwanda, and trends of resistance between 1986 and 2000. Sex. Transm. Dis. (2001) 28:539–545.
   PubMedGoogle Scholar
• OTUBU JAM, IMADE GE, SAGAY AS, TOWOBOLA OA: Resistance of recent Neisseria gonorrhoeae isolates in Nigeria and outcome of single-dose treatment with ciprofloxacin. Infection (1992) 20:339–341.
   PubMedGoogle Scholar
• VAN DYKE E, CRABBE F, NZILA N et al.: Increasing resistance of Neisseria gonorrhoeae in west and central Africa. Consequences of therapy of gonococcal infection. Sex. Transm. Dis. (1997) 24:32–37.
   Google Scholar
• ISON CA, ROOPE NS, DANGOR Y, RADEBE F, BALLARD R: Antimicrobial susceptibilities and serotyping of Neisseria gonorrhoeae in southern Africa: influence of geographical source of infection.Epidemiol Infect. (1993) 110:297–305.
   PubMed Web of Science ®Google Scholar
• WEST B, CHANGALUCHA J, GROSSKURTH H et al.: Antimicrobialsusceptibility, auxotype and plasmid content of Neisseria gonorrhoeae in northern Tanzania: emergence of high level plasmid mediated tetracycline resistance.Genitourin. Med. (1995) 71:9–12.
   PubMed Web of Science ®Google Scholar
• ISON CA, PEPIN J, DEMBA E, SECKA 0, EASMON CS: The dominance of a multiresistant strain of Neisseria gonorrhoeae among prostitutes and STD patients in the Gambia. Genitourin. Med.(1992) 68:356–360.
   PubMedGoogle Scholar
• ADEGBOLA RA, SABALLY S, CORRAH T, WEST B, MABEY D: Increasing prevalence of penicillinase-producing Neisseria gonorrhoeae and emergence of high-level, plasmid-mediated tetracycline resistance among gonococcal isolates in The Gambia. Top. Med. Int. Health (1997) 2:428–432.
   PubMedGoogle Scholar
• MASON PR, GWANZURA L, LATIF AS, MAROWA E, RAYS, KATZENSTEIN DA: Antimicrobial resistance in gonococci isolated from patients and from commercial sex workers in Harare, Zimbabwe. Int. .1 Antimicrob. Agents (1997) 9:175–179.
   Google Scholar
• GUYOT A, JARRETT B, SANVEE L, DORE D: Antimicrobial resistance of Neisseria gonorrhoeae in Liberia. Transact. Royal Soc. Top. Med. Hyg. (1998) 92:670–674.
   PubMedGoogle Scholar
• MOODLEY P, PILLAY C, GOGA R, KHARSANY BMA, STURM W: Evolution in the trends of antimicrobial resistance in Neisseria gonorrhoeae isolated in Durban over a 5 year period: impact of the introduction of syndromic management. Antimicrob. Chemother. (2001) 48:853–859.
   Google Scholar
• MBWANA J, MHALU F, MWAKAGILE D, MASESA J, MOSHIRO C, SANDSTORM E: Susceptibility pattern of Neisseria gonorrhoeae to antimicrobial agents in Dar es Salaam. East Afr. Med. (1999) 76:330–334.
   PubMedGoogle Scholar
• RAHMAN M, ALAM A, NESSA K et al: Treatment failure with the use of ciprofloxacin for gonorrhea correlates with the prevalence of fluoroquinolones-resistant Neisseria gonorrhoeae strains in Bangladesh. Clin. Infect. Dis. (2001) 32:884–889.
   PubMedGoogle Scholar
• ••A clinical study correlating in vitroresistance with therapeutic failure.
   Google Scholar
• WOODFORD N, ISON CA: The effect of media on antimicrobial susceptibility testing of Neisseria gonorrhoeae. Antimicrob. Chemother. (1988) 22:463–471.
   Google Scholar
• NG PP, CHAN RK, LING AE: Gonorrhea treatment failure and ciprofloxacin resistance. Int.' STD AIDS (1998) 9:323–325.
   PubMedGoogle Scholar
• KAM KM, LO KK, CHONG LY et al: Correlation between in vitro quinolone susceptibility of Neisseria gonorrhoeae and outcome of treatment of gonococcal urethritis with single-dose ofloxacin. Clin. Infect. Dis. (1999) 28:1165–1166.
   PubMedGoogle Scholar
• BOGAERT J, TELLO WM, AKINGENEYE J, MUKANTABANA V, VAN DYCK E, PIOT P: Effectiveness of norfloxacin and ofloxacin for treatment of gonorrhea and decrease of in vitro susceptibility to quinolones over time in Rwanda. Cenitourin. Med. (1993) 69:196–200.
   PubMedGoogle Scholar
• CHOWDHRY S, PANDHI D, V IDHANI S, BHALLA P, REDDY BS: High incidence of treatment failure of Neisseria gonorrhoeae isolates to ciprofloxacin in male gonococcal urethritis in Delhi. Int.j STD AIDS (2002) 13:564–567.
   PubMedGoogle Scholar
• ROY K, WANG S, MELTZER M: Identifying the optimal diagnostic and treatment strategy for gonorrhea in a time of increasing ciprofloxacin-resistance [Abstract]. In: Program and Abstracts of the 2002 Conference on Antimicrobial Resistance. Bethesda, Maryland, USA. National Foundation for Infectious Diseases. June 27–29 (2002).
   Google Scholar
• AZNAR J, RODRIGUEZ-PICHARO A, HERNANDEZ I, DE MIGUEL C, PEREA EJ: Comparative clinical efficacy of two different single-dose ciprofloxacin treatments for uncomplicated gonorrhea. Sex. Thansm. Dis. (1986) 13:169–171.
   PubMedGoogle Scholar
• LOO PS, RIDGEWAY GL, ORIEL JD: Single dose ciprofloxacin for treating gonococcal infections in men. Cenitourin. Med. (1985) 61; 302–305.
   PubMedGoogle Scholar
• BELLI L, CASTRO JM, CASCO R: Ciprofloxacin in the treatment of non-complicated gonococcal urethritis. In: Proceedings of the 14th International Congress of Chemotherapy Kyoto, Japan. (1985):1687–1688
   Google Scholar
• PEREA EJ, PRADOS R, DE MIGUEL C, AZNAR J: Single-dose ciprofloxacin treatment of gonococcal urethritis. Proc. Exc. Med. (1985) 34:338–341.
   Google Scholar
• SHAHMANESH M, SKULKA SR, PHILLIP I, WESTWOOD A, THIN RN: Ciprofloxacin for treating urethral gonorrhea in men. Cenitourin. Med. (1986) 62:86–87.
   PubMedGoogle Scholar
• TEGELBERG-STASSEN MJAM, VAN DER HOEK JCS, MOOI L et al.: Treatment of uncomplicated gonococcal urethritis in men with two dosages of ciprofloxacin. Eur.J Clin. Microbiol (1986) 5:244–246.
   Google Scholar
• DE L'EXPOSTO F, DUNCSN MO, DANGOR Y, FEHLER HG, LEIBOWITZ L, BALLARD FC: In vitro activity and clinical efficacy of ciprofloxacin for the treatment of gonorrhea and associated infections. Presented at the 10h International Congress of Chemotherapy Istanbul, Turkey. July 19–24 (1987) Abstract 1201.
   Google Scholar
• AVONTS D, FRANSEN L, VIELFOND J, STEVENS A, HENDRICKX K, PIOT P: Treating uncomplicated gonococcal infection with 250 mg or 100 mg ciprofloxacin in a single oral dose. Cenitourin. Med. (1988) 64:134–137.
   PubMedGoogle Scholar
• SHANMUGARATNAM K, SPROTT MS, PATTMAN RS, KEARNS AM, WATSON PG: Single dose ciprofloxacin to treat women with gonorrhea. Cenitourin. Med. (1989) 65:129.
   PubMedGoogle Scholar
• BALACHANDRAN T, ROBERTS AP, EVANS BA, AZADIAN BS: Single-dose therapy of anogenital and pharyngeal gonorrhea with ciprofloxacin. Int. J. STD AIDS (1992) 3:49–51.
   PubMedGoogle Scholar
• RAJAKUMER MK, NGEOW YE KHOR BS, LIM KF: Ofloxacin, a new quinolone for the treatment of gonorrhea. Sex. Transm. Dis. (1988) 15:25–26.
   PubMedGoogle Scholar
• RICHMOND SJ, BHATTACHARYYA MN, MAITI H, CHOWHURY EH, STIRAND RM, TOOTH JA: The efficacy of ofloxacin against infection caused by Neisseria gonorrhoeae and Chlamydia trachomatis. Antimicrob. Chemother. (1988) 22(Suppl. C):149–153.
   Google Scholar
• HEAP BJ: Low dose oral ofloxacin to treat gonorrhea in Hong Kong. Cenitourin. Med. (1989) 65:198.
   PubMedGoogle Scholar
• MAITI H, CHOWDHURY FH, RICHMOND SJ et al: Ofloxacin in the treatment of uncomplicated gonorrhea and chlamydial genital infection. Clin. Titer. (1991) 13; 441–447.
   Google Scholar
• SMITH BL, CUMMINGS MC, COVINO JM, BENES S, DRAFT K, MCCORMACK WM: Evaluation of ofloxacin in the treatment of uncomplicated gonorrhea. Sex. Thansm. Dis. (1991) 18:18–20.
   PubMed Web of Science ®Google Scholar
• MATSUDA T, TAKEUCHI H, YOSHIDA 0: Clinical efficacy of ofloxacin against male urethritis. Ear: j Clin. Microbiol Infect. Dis. (1991) Special Issue:311-312.
   Google Scholar
• ZIEGLER C, STERY A, MAILER H, KOPP W, GEBHART W, SOLTZ-SZOTS J: Quinolones as an alternative treatment of chlamydial, Mycoplasma and gonococcal urogenital infections. Dermatology (1992) 185:128–131.
   PubMedGoogle Scholar
• ROMANOWSKI B, WOOD H, DRAKER J, TSIANCO MC: Norfloxacin in the therapy of uncomplicated gonorrhea. Antimicrob. Agents Chemother. (1986) 30:514–515.
   PubMed Web of Science ®Google Scholar
• CRISTIANO P: Clinical trial of norfloxacin in the treatment of uncomplicated gonococcal urethritis: preliminary report. Drugs Exp. Clin. Res. (1989) 15:33–35.
   PubMedGoogle Scholar
• NOTOWICZ A, STOLLZ E, VAN KLINGERMAN B: A double blind study comparing two doses of enoxacin for the treatment of uncomplicated urogenital gonorrhea. J. Antimicrobial. Chemother: (1984) 14(Suppl. C):91–94.
   Google Scholar
• TEGELBERG-STASSEN MJ, VAN DER WILLIGEN AH, VAN DER HOEK JCS et al: Treatment of uncomplicated gonorrhea in women with a single dose of enoxacin. Ear: Clin. Microbiol (1986) 5:395–398.
   Google Scholar
• VAN DER WILLIGEN AH, VAN DER HOEK JCS, WAGENVOORT JHT et al.: Comparative double-blind study of 200- and 400-mg enoxacin given orally in the treatment of acute uncomplicated urethral gonorrhea in males. Antimicrobial. Agents Chemother: (1987) 31:535–538.
   Google Scholar
• SIBOULET A, BOHBOT JM, CATALAN A: Enoxacin in the treatment of sexually transmitted diseases. J. Antimicrob. Chemother: (1988) 21 (Suppl. B):119–124.
   Google Scholar
• SMITH BL, CUMMINGS M, BENES S, DRAFT K, MCCORMACK WM: Evaluation of difloxacin in the treatment of uncomplicated urethral gonorrhea in men. Antimicrob. Agents Chemother. (1989) 33:1721–1723.
   PubMedGoogle Scholar
• HOOK EW, PINSON GB, BLALOCK CJ, JOHNSON RB: Dose-ranging study of CP-99,219 (trovafloxacin) for treatment of uncomplicated gonorrhea. Antimicrob. Agents Chemother. (1996) 40:1720–1721.
   PubMedGoogle Scholar
• RODDY RE, HANDSFIELD HH, HOOK EW: Comparative trial of single-dose ciprofloxacin and ampicillin plus probenecid for treatment of gonococcal urethritis in men. Antimicrob. Agents Chemother. (1986) 30:267–269.
   PubMed Web of Science ®Google Scholar
• SCOTT GR, MCMILLAN A, YOUNG H: Ciprofloxacin versus ampicillin and probenecid in the treatment of uncomplicated gonorrhea in men. Antimicrob. Chemother. (1987) 20:117–121.
   Google Scholar
• BELLI I, CASTRO JM, CASTRO YR: Ciprofloxacin in the treatment of uncomplicated gonococcal urethritis. In: Ciprofloxacin: a new era in antibiotics. Arango JC, Bernardo FC, Belli I et al. (Eds) Schwer verlag GmbH, Stuttgart, Germany (1988):75–77.
   Google Scholar
• LASSUS A, KARPPINEN L, INGERVO L et al.: Cipraoxacin versus amoxicillin and probenecid in the treatment of uncomplicated gonorrhea. Scand. J. Infect. Dis. (1989) 60(Suppl):58–61.
   Google Scholar
• TRAISUPA A: The role of ciprofloxacin in sexually transmitted diseases. bit. .1 Clin. Pract. (1990) 6\(Suppl. 1):47–50.
   Google Scholar
• BRYAN JP, HIRA SK, BRADY W et al.: Oral ciprofloxacin versus ceftriaxone for the treatment of urethritis from resistant Neisseria gonorrhoeae in Zambia. Antimicrob. Agents Chemother. (1990) 34:819–822.
   PubMedGoogle Scholar
• NDINYA-ACHOLA 0, ODHIAMBO FA, WAMBUGU P et al.: Ciprofloxacin treatment of gonococcal infections. Proceedings of the gh Meeting of the International Society for Sexually Transmitted Disease Research, Nairobi, Kenya (1991) Abstract P–20–258.
   Google Scholar
• HOOK EW III, JONES RB, MARTIN DH et al.: Comparison of ciprofloxacin and ceftriaxone as single-dose therapy for uncomplicated gonorrhea in women. Antimicrob. Agents Chemother. (1993) 37:1670–1673.
   PubMedGoogle Scholar
• THORPE EW, SCHWEBKE JR, HOOK EW et al.: Comparison of single-dose cefuroxime axetil with ciprofloxacin in treatment of uncomplicated gonorrhea caused by penicillinase-producing and non-penicillinase-producing Neisseria gonorrhoeae. Antimicrob. Agents Chemothr. (1996) 40:2775–2780.
   PubMed Web of Science ®Google Scholar
• BOSLEGO JW, HICKS CB, GREENUP R et al.: A prospective randomised trial of ofloxacin versus doxycycline in the treatment of uncomplicated male urethritis. Sex. Transm. Dis. (1988) 15:186–191.
   PubMedGoogle Scholar
• BLACK JH, LONG JM, ZWICKL BE, RAY BS et al.: Multicenter randomized study of single-dose ofloxacin versus amoxicillin-probenecid for treatment of uncomplicated gonococcal infection. Antimicrob. Agents Chemother: (1989) 33:167–170.
   PubMedGoogle Scholar
• LUTZ FB Jr: Single-dose efficacy of ofloxacin in uncomplicated gonorrhea. Am. J. Med. (1989) 87:69S–74S.
   Google Scholar
• COVINO JM, CUMMINGS M, SMITH B, BENES S, DRAFT K, MCCORMACK WM: Comparison of ofloxacin and ceftriaxone in the treatment of uncomplicated gonorrhea caused by penicillinase-producing and non-penicillinase producing strains. Antimicrob. Agents Chemother. (1990) 34:148–149.
   PubMedGoogle Scholar
• CRIDER SR, COLBY SD, MILLER LK, HARRISON WO, KERBS SB, BERG SW: Treatment of penicillin-resistant Neisseria gonorrhoeae with oral norfloxacin. N Engl. J. Med. (1984) 311:137–140.
   PubMed Web of Science ®Google Scholar
• KAPLOWITZ LG, VISHNIASKY N, EVANS T et al: Norfloxacin in the treatment of uncomplicated gonococcal infections. Am. J. Med. (1987) 82(6B):35–39.
   Google Scholar
• BOGAERTS J, MARTINEZ TELLO W, VERBIST L, PIOT P, VENDEPITTE J: Norfloxacin versus thiamphenicol for treatment of uncomplicated gonorrhea in Rwanda. Antimicrob. Agents Chemother. (1987) 31:434–437.
   PubMed Web of Science ®Google Scholar
• PANIKABUTRA K, LEE CT, HO B, BAMBERG P: Single dose oral norfloxacin or intramuscular spectinomycin to treat gonorrhea (PPNG and non-PPNG infections): analysis of efficacy and patient preference. Genitourin. Med. (1988) 64:235–240.
   PubMedGoogle Scholar
• TIO TT, SINDHUMATA IR, WAGENVOORT JHT et al.: Pefloxacin compared with cefotaxime for treating men with uncomplicated gonococcal urethritis. Antimicrob. Chemother: (1990) 22(Suppl. B):141–146.
   Google Scholar
• CHEONG LL, CHAN RK, NADARAJAH M: Pefloxacin and ciprofloxacin in the treatment of uncomplicated gonococcal urethritis in males. Genitourin. Med. (1992) 68:260–262.
   PubMedGoogle Scholar
• LEOW YR, CHAN RK, CHEONG LL, GOH CL, NADARAJAH M: Comparing the efficacy of pefloxacin and ciprofloxacin in the treatment of acute uncomplicated gonococcal urethritis in males.Ann. Acad. Med. Singapore. (1995) 24:515–518.
   PubMedGoogle Scholar
• PABST KM, SIEGEL NA, SMITH S, BLACK JR, HANDSFIELD HH, HOOK EW III: Multcentre comparative study of enoxacin and ceftriaxone for treatment of uncomplicated gonorrhea. Sex. Transm. Dis. (1989) 16:148–151.
   PubMedGoogle Scholar
• ALBRECHT LM, RYBAK MJ, SCHUBINER, WEINER LM: Single dose enoxacin for the treatment of uncomplicated urogenital gonorrhea. Sex. Transm. Dis. (1989) 16:114–117.
   PubMedGoogle Scholar
• COVINO JM, SMITH BL,CUMMINGS MC, BENES S, DRAFT K, MCCORMACK WM: Comparison of enoxacin and ceftriaxone in the treatment of uncomplicated gonorrhea. Sex. Transm. Dis. (1993) 20:227–229.
   PubMedGoogle Scholar
• LASSUS A, ABATH FILHO L, SANTOS JUNIOR MF, BELLI L: Comparison of Fleroxacin and penicillin G plus probenecid in the treatment of acute uncomplicated gonococcal infections.Genitourin. Med. (1992) 68:317–320.
   PubMedGoogle Scholar
• SMITH BL, MOGABGAB WJ, DALU Z et al.: Multicenter trial of Fleroxacin versus ceftriaxone in the treatment of uncomplicated gonorrhea.Arn. J. Med. (1993) 94(3A):815–845.
   Google Scholar
• MOGABGAB W, BUNTIN DM: Single-dose therapy of uncomplicated gonococcal urethritis or cervicitis: oral temafloxacin versus intramuscular ceftriaxone.Eur. Clin. Microbial. Infect. Dis. (1991) Special Issue:205-206.
   Google Scholar
• MOI H, MOREL P, GIANOTTI B, BARLOW D, PHILLIPS I, JEAN C: Comparative efficacy and safety of single oral doses of sparfloxacin versus ciprofloxacin in the treatment of acute gonococcal urethritis in men. J. Antimicrob. Chemother: (1996) 37(Suppl. A):115–122.
   Google Scholar
• JONES RB, SCHWEBKE J,THORPE EM, DALU ZA, LEONE P, JOHNSON RB: Randomized trial of trovafloxacin and ofloxacin for single-dose therapy of gonorrhea. Trovafloxacin Gonorrhea Study Group.\Arn. J. Med. (1998) 104:28–32.
   Google Scholar
• STONER BP, DOUGLAS JM,MARTIN DH et al.: Single-dose gatifloxacin compared with ofloxacin for the treatment of uncomplicated gonorrhea: a randomized, double-blind, Multicenter trial. Sex. Transm. Dis. (2001) 28:136–142.
   Google Scholar
• COKER DM, AHMED-JUSHUF I, ARYA OP, CHESSBROUGH JS, PRATT BC: Evaluation of single dose ciprofloxacin in the treatment of rectal and pharyngeal gonorrhea. J. Antimicreb. Chemether. (1989) 24:271–272.
   PubMedGoogle Scholar
• BAKHTIAR M, SAMARASINGHE PL: Enoxacin as one day oral treatment of men with anal or pharyngeal gonorrhea. Geniteurin. Med. (1988) 64:364–366.
   PubMedGoogle Scholar
• ROMANOWSKI B, HARDY IS, RAFTER MS, DRAKERJ: Enoxacin in the therapy of anal and pharyngeal gonococcal infections. Sex. 7iansm. Dis. (1989) 16:190–191.
   Google Scholar
• CORRADO ML: The clinical experience with ofloxacin in the treatment in sexually transmitted diseases. Obstet. Gynecel. (1991) 164:1396–1399.
   Google Scholar
• NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS: Performance standards for antimicrobial susceptibility testing. M100-S12. National Committee for Clinical Laboratory Standards, Wayne, PA, USA (2002) 22:53–55.
   Google Scholar
• GUOMING L, QUN C,SHENGCHUN W: Resistance of Neisseria gonorrhoeae epidemic strains to antibiotics: report of resistant isolates and surveillance in Zhanjiang, China: 1998 to 1999.Sex. Transm. Drs. (2000) 27:115–118.
   PubMed Web of Science ®Google Scholar
• ABEYEWICKEREME I, SENARATNE L, PRITHIVIRAJ VB: Rapid emergence of 4-fluoroquinolone resistance with associated decline in penicillinase-producing Neisseria gonorrhoeae in Colombo, Sri Lanka. Geniteurin. Med. (1996) 72:302.
   PubMedGoogle Scholar
• ISON CA, MARTIN IM: Susceptibility of gonococci isolated in London to therapeutic antibiotics: establishment of a London surveillance programme. London Gonococcal Working Group.Sex. Transm. Infect. (1999) 75:107–111.
   PubMedGoogle Scholar
• HOOK EW 3rd, MCCORMACK WM, MARTIN D, JONES RB, BEAN K, MAROLI AN: Comparison of single-dose grepafloxacin with cefixime for treatment of uncomplicated gonorrhea in men, The STD Study Group. Antimicreb. Agents Chemether: (1997) 41:1843–1845.
   Google Scholar
• WORLD HEALTH ORGANIZATION: Management of sexually transmitted diseases. WHO/UNAIDS (1997) WHO/GPA/94.1 Rev. 1.
   Google Scholar
• http://www.who.int/hiv/pub/sti/who_hiv_ai ds_2001.02.pdf Global prevalence and incidence of selected curable sexually transmitted infections.
   Google Scholar
• •A recent report of the worldwide distribution of gonorrhea.
   Google Scholar
• http://www.health.gov.il/units/epi DEPARTMENT OF EPIDEMIOLOGY: Weekly epidemiological report (Online) 2002.
   Google Scholar